会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明授权
    • TRP channel family member, LTRPC3 polypeptides
    • TRP频道家庭成员,LTRPC3e
    • US07504481B2
    • 2009-03-17
    • US10405793
    • 2003-03-28
    • Ning LeeJian ChenJohn N. FederShujian WuLiana M. LeeMichael A. Blanar
    • Ning LeeJian ChenJohn N. FederShujian WuLiana M. LeeMichael A. Blanar
    • C07K1/00C12P21/06C12P21/04C12N15/00A61K39/00
    • C07K14/705A61K38/00C07K2319/00
    • The present invention provides novel polynucleotides encoding LTRPC3 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of LTRPC3 polypeptides, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing the novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel LTRPC3, LTRPC3b, LTRPC3c, LTRPC3d, LTRPC3e, and LTRPC3f polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
    • 本发明提供了编码LTRPC3多肽的新型多核苷酸,其片段及其同源物。 本发明还提供了分别编码LTRPC3多肽,LTRPC3b,LTRPC3c,LTRPC3d,LTRPC3e和LTRPC3f的变体和剪接变体的多核苷酸。 还提供了用于产生新型LTRPC3,LTRPC3b,LTRPC3c,LTRPC3d,LTRPC3e和LTRPC3f多肽的载体,宿主细胞,抗体以及重组和合成方法。 本发明还涉及将这些新型LTRPC3,LTRPC3b,LTRPC3c,LTRPC3d,LTRPC3e和LTRPC3f多肽应用于诊断,治疗和/或预防与这些多肽相关的各种疾病和/或病症的诊断和治疗方法。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。
    • 9. 发明授权
    • Polypeptide for a TRP channel family member, TRP-PLIK2, and splice variants
    • 用于TRP通道家族成员的多肽,TRP-PLIK2和剪接变体
    • US07541434B2
    • 2009-06-02
    • US11726234
    • 2007-03-21
    • Ning LeeJian ChenShujian WuHan ChangMichael A. Blanar
    • Ning LeeJian ChenShujian WuHan ChangMichael A. Blanar
    • C07K14/47C12N15/07C12N15/64C12P21/02
    • C07K14/705
    • The present invention provides novel polynucleotides encoding TRP-PLIK2 polypeptides, fragments and homologues thereof. The present invention also provides polynucleotides encoding variants and splice variants of TRP-PLIK2 polypeptides, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d, respectively. Also provided are vectors, host cells, antibodies, and recombinant and synthetic methods for producing said polypeptides. The invention further relates to diagnostic and therapeutic methods for applying these novel TRP-PLIK2, TRP-PLIK2b, TRP-PLIK2c, and TRP-PLIK2d polypeptides to the diagnosis, treatment, and/or prevention of various diseases and/or disorders related to these polypeptides. The invention further relates to screening methods for identifying agonists and antagonists of the polynucleotides and polypeptides of the present invention.
    • 本发明提供了编码TRP-PLIK2多肽的新型多核苷酸,其片段及其同源物。 本发明还提供分别编码TRP-PLIK2多肽,TRP-PLIK2b,TRP-PLIK2c和TRP-PLIK2d的变体和剪接变体的多核苷酸。 还提供了载体,宿主细胞,抗体以及用于产生所述多肽的重组和合成方法。 本发明还涉及将这些新型TRP-PLIK2,TRP-PLIK2b,TRP-PLIK2c和TRP-PLIK2d多肽应用于诊断,治疗和/或预防与这些相关的各种疾病和/或病症的诊断和治疗方法 多肽。 本发明还涉及用于鉴定本发明的多核苷酸和多肽的激动剂和拮抗剂的筛选方法。